X Bioscience PCL (XBIO)

Thailand

Currency in THB

0.07

0.00(0.00%)

Closed·27/03

Fair Value

Unlock Value

Day's Range

0.06

0.07

52 wk Range

0.04

1.27

XBIO Income Statement

Assess the X Bioscience PCL income statement, providing a detailed view of the company’s financial performance across activities. This statement outlines key financial figures such as revenue, expenses, operating income, and net income. Assess the XBIO net worth.

Period Ending:

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

2025

31/12

Total Revenues

aa.aa

254.04

344.49

311.77

319.24

129.65

Total Revenues Growth

aa.aa

-38.88%

+35.6%

-9.5%

+2.4%

-59.39%

Cost Of Revenues

aa.aa

126.82

172.3

159.67

180.63

76.61

Gross Profit

aa.aa

127.23

172.18

152.11

138.61

53.04

Gross Profit Growth

aa.aa

-1.85%

+35.34%

-11.66%

-8.87%

-61.73%

Gross Profit Margin %

aa.aa

50.08%

49.98%

48.79%

43.42%

40.91%

Other Operating Expenses, Total

aa.aa

227.79

455.41

272.53

389.82

507.35

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-12.81%	+99.93%	-40.16%	+43.04%	+30.15%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	227.79	455.41	272.53	389.82	507.35
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

aa.aa

-100.56

-283.23

-120.43

-251.21

-454.31

Operating Income Growth

aa.aa

+23.6%

-181.65%

+57.48%

-108.6%

-80.85%

EBIT Margin %

aa.aa

-39.58%

-82.22%

-38.63%

-78.69%

-350.4%

Net Interest Expenses

aa.aa

-14.44

-56.52

-39.94

-34.29

-26.22

Net Interest Expenses Growth

aa.aa

+12.17%

-291.45%

+29.33%

+14.15%

+23.54%

Interest Expense, Total

aa.aa

-14.45

-56.52

-39.94

-34.29

-26.22

Interest And Investment Income

aa.aa

0.01

Other Non Operating Expenses, Total

aa.aa

9.45

3.33

11.72

7.58

6.26

EBT, Excl. Unusual Items

aa.aa

-105.55

-336.41

-148.65

-277.92

-474.26

Gain (Loss) On Sale Of Assets

aa.aa

18.53

Other Unusual Items, Total

aa.aa

EBT, Incl. Unusual Items

aa.aa

-105.55

-336.41

-148.65

-277.92

-455.74

EBT, Incl. Unusual Items Growth

aa.aa

+54.97%

-218.73%

+55.81%

-86.96%

-63.98%

EBT, Incl. Unusual Items Margin

aa.aa

-41.55%

-97.66%

-47.68%

-87.05%

-351.5%

Income Tax Expense

aa.aa

-5.65

-1.13

-15.84

-3.25

Net Income to Company

aa.aa

-276.45

-575.99

-147.52

-262.07

-469.43

Minority Interest

aa.aa

1.85

0.57

Net Income

aa.aa

-276.45

-575.99

-147.52

-260.22

-468.87

Net Income Growth

aa.aa

-15.76%

-108.35%

+74.39%

-76.4%

-80.18%

Net Income Margin %

aa.aa

-108.82%

-167.2%

-47.32%

-81.51%

-361.63%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

-99.9

-330.77

-147.52

-260.22

-451.92

Basic EPS - Continuing Operations

aa.aa

-0.86

-2.84

-1.18

-1.41

-1.13

Basic EPS - Continuing Operations Growth

aa.aa

+65.08%

-231.1%

+58.62%

-20.09%

+20.41%

Diluted EPS - Continuing Operations

aa.aa

-0.86

-2.84

-1.18

-1.41

-1.13

Diluted EPS - Continuing Operations Growth

aa.aa

+65.08%

-231.1%

+58.62%

-20.09%

+20.41%

Basic Weighted Average Shares Outstanding

aa.aa

116.27

125.32

184.08

401.67

Diluted Weighted Average Shares Outstanding

aa.aa

116.27

125.32

184.08

401.67

Dividend Per Share

aa.aa

Dividend Per Share Growth

aa.aa

EBITDA

aa.aa

-13.51

-189.44

-102.69

-224.53

-436.4

EBITDA Growth

aa.aa

+79.39%

-1,301.73%

+45.79%

-118.65%

-94.36%

EBITDA Margin %

aa.aa

-5.32%

-54.99%

-32.94%

-70.33%

-336.59%

EBIT

aa.aa

-100.56

-283.23

-120.43

-251.21

-454.31

* In Millions of THB (except for per share items)

FAQ

What was X Bioscience PCL’s revenue at year end?

At the end of the last reported fiscal year, X Bioscience PCL (XBIO) recorded total revenue of 129.65 million THB.

How much revenue did X Bioscience PCL report in the most recent quarter?

In its most recent quarterly earnings report, X Bioscience PCL posted revenue of 23.87 million THB.

What was X Bioscience PCL’s net income for the year?

For the full year, X Bioscience PCL reported net income of -468.87 million THB.

How much net income did X Bioscience PCL post in the last quarter?

In the most recent quarter, X Bioscience PCL (XBIO) posted net income of -207.54 million THB.

What was X Bioscience PCL’s gross profit for the year?

Gross profit for the year was reported at 53.04 million THB.

How much gross profit did X Bioscience PCL generate last quarter?

X Bioscience PCL recorded gross profit of 11.07 million THB in its latest quarterly report.

What was X Bioscience PCL’s annual operating income?

For the full year, X Bioscience PCL (XBIO) reported operating income of -454.31 million THB.

What was X Bioscience PCL’s operating income last quarter?

Quarterly operating income was -206.07 million THB.

What was X Bioscience PCL’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at -202.13 million THB.

What was the quarter-over-quarter change in EBITDA for X Bioscience PCL?

EBITDA changed by -81.94% million THB compared to the last quarter.

What is X Bioscience PCL’s most recent gross profit margin?

The latest reported gross profit margin for X Bioscience PCL (XBIO) is 46.35% million THB.

What is X Bioscience PCL’s most recent net income margin?

Net income margin based on recent financials is -869.30% million THB.

What is X Bioscience PCL’s most recent EBIT margin?

X Bioscience PCL reported an EBIT margin of -863.17% million THB based on current figures.

How did X Bioscience PCL’s revenue change compared to the previous quarter?

Revenue changed by -7.31% million THB compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for X Bioscience PCL?

In the latest quarter, gross profit changed by -9.98% million THB from the previous quarter.

S&P/TSX

31,960.65

+73.13

+0.23%

S&P/TSX 60

1,861.99

-0.28

-0.02%

US 30

45,043.30

-916.1

-1.99%

US 500

6,352.00

-125.1

-1.93%

S&P 500 VIX

31.05

+3.61

+13.16%

DAX

22,300.75

-312.22

-1.38%

Dollar Index

99.98

+0.270

+0.27%

Market Movers

Name	Last	Chg. %	Vol.
Canadian Natural	69.46	+2.87%	21.28M
TC Energy	88.15	-0.09%	8.60M
Suncor Energy	92.50	+2.71%	7.37M
Toronto Dominion Bank	126.87	-1.39%	5.40M
Bank of Nova Scotia	94.09	-0.98%	5.05M
RBC	219.85	-0.97%	3.78M
National Bank of Canada	177.49	-0.88%	2.19M

Name	Last	Chg. %	Vol.
PeakBirch Logic	0.030	+500.00%	1.32K
New Leaf Ventures	0.05	+400.00%	666.82K
Grand Peak	0.0950	+216.67%	11.00K
EnviroMetal Technologies	0.01	+200.00%	1.09K
EnviroMetal Technologies	0.015	+200.00%	1.09K
Irwin Naturals	0.30	+150.00%	3.24K
Moss Genomics	0.07	+150.00%	1.00K

Name	Last	Chg. %	Vol.
Rivalry	0.01	-100.00%	2.00K
Metamaterial	0.25	-92.86%	0.00
Ravelin Properties REIT Unt	0.02	-75.00%	3.95M
Mary Agrotechnologies	0.03	-57.14%	1.50K
Canada Carbon Inc.	0.005	-50.00%	165.12K
Running Fox Resource Corp.	0.0050	-50.00%	75.00K
Alturas Minerals	0.005	-50.00%	5.44K

Trending Stocks

Name	Last	Chg. %	Vol.
Canadian Natural	69.46	+2.87%	21.28M
TELUS	17.73	-0.67%	5.40M
Dollarama	166.76	-1.23%	778.75K
Whitecap Resources	15.54	+3.95%	10.55M
Cenovus Energy Inc	37.23	+3.39%	9.73M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
A A Aaaaa	36.42	+63.57%	59.57
Aaaaaa Aaaaa Aaaa	5.24	+62.51%	8.52
Aaaaaaaaaaa	16.01	+57.56%	25.23
Aaaaa Aaa A A	9.78	+48.84%	14.56
Aaaaa Aaaaaaaaaa	5.89	+48.25%	8.73
Aaaaaaaaaa Aaaaaaaa	2,358.89	+47.90%	3,488.80
Aaaaaaa Aaaaaaaaa	126.87	+45.76%	184.93

Name	Last	Upside	Fair Value
A A Aaaaa	36.42	+63.57%	59.57
Aaaaaa Aaaaa Aaaa	5.24	+62.51%	8.52
Aaaaaaaaaaa	16.01	+57.56%	25.23
Aaaaa Aaa A A	9.78	+48.84%	14.56
Aaaaa Aaaaaaaaaa	5.89	+48.25%	8.73
Aaaaaaaaaa Aaaaaaaa	2,358.89	+47.90%	3,488.80
Aaaaaaa Aaaaaaaaa	126.87	+45.76%	184.93

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

X Bioscience PCL (XBIO)

XBIO Income Statement

FAQ

What was X Bioscience PCL’s revenue at year end?

How much revenue did X Bioscience PCL report in the most recent quarter?

What was X Bioscience PCL’s net income for the year?

How much net income did X Bioscience PCL post in the last quarter?

What was X Bioscience PCL’s gross profit for the year?

How much gross profit did X Bioscience PCL generate last quarter?

What was X Bioscience PCL’s annual operating income?

What was X Bioscience PCL’s operating income last quarter?

What was X Bioscience PCL’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for X Bioscience PCL?

What is X Bioscience PCL’s most recent gross profit margin?

What is X Bioscience PCL’s most recent net income margin?

What is X Bioscience PCL’s most recent EBIT margin?

How did X Bioscience PCL’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for X Bioscience PCL?

Trending Stocks